Gastroenterology
News
FDA reports shortage of doxorubicin for injection, initiates importation
News
Early results promising for pembrolizumab in combination regimens for NSCLC
Key clinical point: Overall response rates ranged from 30% to 71% when pembrolizumab was added to chemotherapy combinations or paired with an R2...
News
Task force affirms value of colorectal cancer screening
Colorectal cancer screening by a variety of methods is worthwhile and recommended for all adults aged 50-75 years, according to the latest...
News
‘Meticulous’ surgical procedure best defense against rectal cancer recurrence
In the clinical experience of Dr. Ian C. Lavery, prevention efforts are the best defense against local recurrence of rectal cancer.
Conference Coverage
Tissue flap reconstruction associated with higher costs, postop complication risk
LOS ANGELES – The use of locoregional tissue flaps in combination with abdominoperineal resection was associated with higher rates of...
Conference Coverage
Preoperative chemotherapy improves survival in patients with large anorectal GIST
The size of anorectal gastrointestinal stroma tumors and preop chemotherapy are the most important determinants of survival following resection,...
News
MyPathway: Targeted therapies show promise in nonindicated tumors
Agents that target the HER2, BRAF, Hedgehog, or EGFR pathways show promise in nonindicated tumor types that harbor these molecular alterations,...
Conference Coverage
Liquid biopsies prove useful alternative to tissue biopsies
Liquid biopsy, the testing of the blood for circulating tumor DNA (ctDNA), identified cancer mutations useful as biomarkers – many associated with...
Conference Coverage
Anticlaudin antibody increases survival in advanced gastric cancer
Key clinical point: A novel monoclonal antibody in combination with chemotherapy increased overall and progression-free survival in advanced...
Video
VIDEO: Dr. Roy Herbst talks combinations, evolutions, and innovations in lung cancer
Conference Coverage
Neoadjuvant chemo found to benefit locally advanced colon cancer
Treatment with neoadjuvant chemotherapy leads to significant downstaging in a selected group of patients with advanced colon cancer, results from...